1696 Stock Overview
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa.
Sisram Medical Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$11.62|
|52 Week High||HK$16.48|
|52 Week Low||HK$4.80|
|1 Month Change||-3.01%|
|3 Month Change||48.21%|
|1 Year Change||-20.19%|
|3 Year Change||233.91%|
|5 Year Change||n/a|
|Change since IPO||43.10%|
Recent News & Updates
Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?
Sisram Medical Ltd ( HKG:1696 ), might not be a large cap stock, but it received a lot of attention from a substantial...
|1696||HK Medical Equipment||HK Market|
Return vs Industry: 1696 exceeded the Hong Kong Medical Equipment industry which returned -52.8% over the past year.
Return vs Market: 1696 exceeded the Hong Kong Market which returned -21.6% over the past year.
|1696 Average Weekly Movement||10.8%|
|Medical Equipment Industry Average Movement||8.2%|
|Market Average Movement||6.5%|
|10% most volatile stocks in HK Market||12.6%|
|10% least volatile stocks in HK Market||3.2%|
Stable Share Price: 1696 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: 1696's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectables, personal care, aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company manufactures, distributes, and sells medical equipment.
Sisram Medical Fundamentals Summary
|1696 fundamental statistics|
Is 1696 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|1696 income statement (TTM)|
|Cost of Revenue||US$127.43m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Aug 19, 2022
|Earnings per share (EPS)||0.067|
|Net Profit Margin||10.62%|
How did 1696 perform over the long term?See historical performance and comparison
1.3%Current Dividend Yield
Does 1696 pay a reliable dividends?See 1696 dividend history and benchmarks
|Sisram Medical dividend dates|
|Ex Dividend Date||Aug 19 2022|
|Dividend Pay Date||Sep 02 2022|
|Days until Ex dividend||2 days|
|Days until Dividend pay date||16 days|
Does 1696 pay a reliable dividends?See 1696 dividend history and benchmarks
Is 1696 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1696?
Other financial metrics that can be useful for relative valuation.
|What is 1696's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 1696's PE Ratio compare to its peers?
|1696 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
1858 Beijing Chunlizhengda Medical Instruments
1789 AK Medical Holdings
1302 LifeTech Scientific
3600 Modern Dental Group
1696 Sisram Medical
Price-To-Earnings vs Peers: 1696 is good value based on its Price-To-Earnings Ratio (22.1x) compared to the peer average (31.1x).
Price to Earnings Ratio vs Industry
How does 1696's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price-To-Earnings vs Industry: 1696 is expensive based on its Price-To-Earnings Ratio (22.1x) compared to the Hong Kong Medical Equipment industry average (16.3x)
Price to Earnings Ratio vs Fair Ratio
What is 1696's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||22.1x|
|Fair PE Ratio||20.8x|
Price-To-Earnings vs Fair Ratio: 1696 is expensive based on its Price-To-Earnings Ratio (22.1x) compared to the estimated Fair Price-To-Earnings Ratio (20.8x).
Share Price vs Fair Value
What is the Fair Price of 1696 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 1696 (HK$11.62) is trading below our estimate of fair value (HK$11.83)
Significantly Below Fair Value: 1696 is trading below fair value, but not by a significant amount.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Sisram Medical forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1696's forecast earnings growth (22.3% per year) is above the savings rate (1.6%).
Earnings vs Market: 1696's earnings (22.3% per year) are forecast to grow faster than the Hong Kong market (16.8% per year).
High Growth Earnings: 1696's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1696's revenue (17.8% per year) is forecast to grow faster than the Hong Kong market (10% per year).
High Growth Revenue: 1696's revenue (17.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1696's Return on Equity is forecast to be low in 3 years time (12%).
Discover growth companies
How has Sisram Medical performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1696 has high quality earnings.
Growing Profit Margin: 1696's current net profit margins (10.6%) are higher than last year (8.2%).
Past Earnings Growth Analysis
Earnings Trend: 1696's earnings have grown by 16.8% per year over the past 5 years.
Accelerating Growth: 1696's earnings growth over the past year (134.2%) exceeds its 5-year average (16.8% per year).
Earnings vs Industry: 1696 earnings growth over the past year (134.2%) exceeded the Medical Equipment industry 35.4%.
Return on Equity
High ROE: 1696's Return on Equity (8.1%) is considered low.
Discover strong past performing companies
How is Sisram Medical's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 1696's short term assets ($297.6M) exceed its short term liabilities ($83.6M).
Long Term Liabilities: 1696's short term assets ($297.6M) exceed its long term liabilities ($43.0M).
Debt to Equity History and Analysis
Debt Level: 1696 has more cash than its total debt.
Reducing Debt: 1696's debt to equity ratio has reduced from 492.5% to 1.8% over the past 5 years.
Debt Coverage: 1696's debt is well covered by operating cash flow (443.9%).
Interest Coverage: 1696's interest payments on its debt are well covered by EBIT (29.2x coverage).
Discover healthy companies
What is Sisram Medical current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: 1696's dividend (1.35%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.87%).
High Dividend: 1696's dividend (1.35%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.31%).
Stability and Growth of Payments
Stable Dividend: 1696 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 1696 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: 1696 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: 1696 is not paying a notable dividend for the Hong Kong market.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Lior Dayan (52 yo)
Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and is responsible for its overall and day-to-day management and development. Mr. Dayan...
CEO Compensation Analysis
Compensation vs Market: Lior's total compensation ($USD1.59M) is above average for companies of similar size in the Hong Kong market ($USD548.44K).
Compensation vs Earnings: Lior's compensation has increased by more than 20% in the past year.
Experienced Management: 1696's management team is considered experienced (4 years average tenure).
Experienced Board: 1696's board of directors are considered experienced (5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Sisram Medical Ltd's employee growth, exchange listings and data sources
- Name: Sisram Medical Ltd
- Ticker: 1696
- Exchange: SEHK
- Founded: 2013
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: HK$5.417b
- Shares outstanding: 466.16m
- Website: https://www.sisram-medical.com
Number of Employees
- Sisram Medical Ltd
- Ofek Building 15
- HaHarash Street 18
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/16 00:00|
|End of Day Share Price||2022/08/16 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.